Docosahexaenoic acid: Nutrient and precursor of bioactive lipids

European Journal of Lipid Science and Technology

Volumn 110, Issue 8, 2008, Pages 673-678

  Lagarde, Michel ^a,b  

^a Univ Lyon   (France)

^b INSERM   (France)

Author keywords

Brain; Lipoxygenases; Oxidative stress; Platelets

Indexed keywords

EID: 54549124697     PISSN: 14387697     EISSN: 14389312     Source Type: Journal    
DOI: 10.1002/ejlt.200800087     Document Type: Review

References (61)

1. M. I. Aveldaño, H. Sprecher: Very long chain (C24 to C36) polyenoic fatty acids of the n-3 and n-6 series in dipolyunsaturated phosphatidylcholines from bovine retina. J Biol Chem. 1987, 262, 1180-1186.
2. H. Sprecher: Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim Biophys Acta. 2000, 1486, 219-231.
3. U. Diczfalusy: Beta-oxidation of eicosanoids. Prog Lipid Res. 1994, 33, 403-428.
4. G. Burdge: Alpha-linolenic acid metabolism in men and women: nutritional and biological implications. Curr Opin Clin Nutr Metab Care.3 2004, 7, 137-144.
5. N. Salem Jr, B. Litman, H. Y. Kim, K. Gawrisch: Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids. 2001, 36, 945-959.
6. N. G. Bazan: Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection. Curr Opin Clin Nutr Metab Care. 2007, 10, 136-141.
7. P. Barberger-Gateau, C. Raffaitin, L. Letenneur, C. Berr, C. Tzourio, J. F. Dartigues, A. Alpérovitch: Dietary patterns and risk of dementia: The Three-City cohort study. Neurology. 2007, 69, 1921-1930.
8. S. I. Rapoport: In vivo fatty acid incorporation into brain phosholipids in relation to plasma availability, signal transduction and membrane remodeling. J Mol Neurosci. 2001, 16, 243-61; discussion 279-284.
9. N. J. Abbott, L. Rönnbäck, E. Hansson: Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci. 2006, 7, 41-53.
10. A. Jonas: Lecithin cholesterol acyltransferase. Biochim Biophys Acta. 2000, 1529, 245-256.
11. P. V. Subbaiah, M. Liu, P. J. Bolan, F. Paltauf: Altered positional specificity of human plasma lecithin-cholesterol acyltransferase in the presence of sn-2 arachidonoyl phosphatidyl cholines. Mechanism of formation of saturated cholesteryl esters. Biochim Biophys Acta. 1992, 1128, 83-92.
12. P. V. Subbaiah, J. M. Sowa, M. H. Davidson: Evidence for altered positional specificity of LCAT in vivo: studies with docosahexaenoic acid feeding in humans. J Lipid Res. 2004, 45, 2245-2251.
13. S. Chen, P. V. Subbaiah: Phospholipid and fatty acid specificity of endothelial lipase: Potential role of the enzyme in the delivery of docosahexaenoic acid (DHA) to tissues. Biochim Biophys Acta. 2007, 1771, 1319-1328.
14. A. Sovic, U. Panzenboeck, A. Wintersperger, I. Kratzer, A. Hammer, S. Levak-Frank, S. Frank, D. J. Rader, E. Malle, W. Sattler: Regulated expression of endothelial lipase by porcine brain capillary endothelial cells constituting the blood-brain barrier. J Neurochem. 2005, 94, 109-119.
15. F. Thiès, C. Pillon, P. Moliere, M. Lagarde, J. Lecerf: Preferential incorporation of sn-2 lysoPC DHA over unesterified DHA in the young rat brain. Am J Physiol. 1994, 267, R1273-1279.
16. F. Thiès F, M. C. Delachambre, M. Bentejac, M. Lagarde, J. Lecerf: Unsaturated fatty acids esterified in 2-acyl-llysophosphatidylcholine bound to albumin are more efficiently taken up by the young rat brain than the unesterified form. J Neurochem. 1992, 59, 1110-1116.
17. R. Cecchelli, V. Berezowski, S. Lundquist, M. Culot, M. Renftel, M. P. Dehouck, L. Fenart: Modelling of the bloodbrain barrier in drug discovery and development. Nat Rev Drug Discov. 2007, 6, 650-661.
18. 13C]docosahexaenoic acid triglycerides in the rat. Am J Physiol. 1996, 270, R846-854.
19. G. R. Ward, Y. S. Huang, E. Bobik, H. C. Xing, L. Mutsaers, N. Auestad, M. Montalto, P. Wainwright: Long-chain polyunsaturated fatty acid levels in formulae influence deposition of docosahexaenoic acid and arachidonic acid in brain and red blood cells of artificially reared neonatal rats. J Nutr. 1998, 128, 2473-2487.
20. J. T. Brenna, G. Y. Diau: The influence of dietary docosahexaenoic acid and arachidonic acid on central nervous system polyunsaturated fatty acid composition. Prostaglandins Leukot Essent Fatty Acids. 2007, 77, 247-250.
21. 13C] docosahexaenoic acid in two lipid forms to blood cells. J Lipid Res. 1997, 38, 1571-1582.
22. M. Lagarde: Metabolism of n-3/n-6 fatty acids in blood and vascular cells. Biochem Soc Trans. 1990, 18, 770-772.
23. D. Lemaitre-Delaunay, C. Pachiaudi, M. Laville, J. Pousin, M. Armstrong, M. Lagarde: Blood compartmental metabolism of docosahexaenoic acid (DHA) in humans after ingestion of a single dose of [(13)C]DHA in phosphatidylcholine. J Lipid Res. 1999, 40, 1867-1874.
24. M. Cansell, F. Nacka, N. Combe: Marine lipid-based liposomes increase in vivo FA bioavailability. Lipids. 2003, 38, 551-559.
25. B. Dehouck, L. Fenart, M. P. Dehouck, A. Pierce, G. Torpier, R. Cecchelli: A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier. J Cell Biol. 1997, 138, 877-889.
26. N. Bernoud, L. Fenart, P. Molière, M. P. Dehouck, M. Lagarde, R. Cecchelli, J. Lecerf: Preferential transfer of 2-docosahexaenoyl-1- lysophosphatidylcholine through an in vitro blood-brain barrier over unesterified docosahexaenoic acid. J Neurochem. 1999, 72, 338-345.
27. P. V. Subbaiah, C. H. Chen, J. D. Bagdade, J. J. Albers: Substrate specificity of plasma lysolecithin acyltransferase and the molecular species of lecithin formed by the reaction. J Biol Chem. 1985, 260, 5308-5314.
28. M. Croset, N. Brossard, A. Polette, M. Lagarde: Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. Biochem J. 2000, 345, 61-67.
29. A. Polette, C. Deshayes, B. Chantegrel, M. Croset, J. M. Armstrong, M. Lagarde: Synthesis of acetyl, docosahexaenoyl-glycerophosphocholine and its characterization using nuclear magnetic resonance. Lipids. 1999, 34, 1333-1337.
30. J. E. Brown, K. W. Wahle: Effect of fish-oil and vitamin E supplementation on lipid peroxidation and whole-blood aggregation in man. Clin Chim Acta. 1990, 193, 147-156.
31. F. M. Sacks, P. H. Stone, C. M. Gibson, D. I. Silverman, B. Rosner, R. C. Pasternak: Controlled trial of fish oil for regression of human coronary atherosclerosis. HARP Research Group. J Am Coll Cardiol. 1995, 25, 1492-1498.
32. J. P. Allard, R. Kurian, E. Aghdassi, R. Muggli, D. Royall: Lipid peroxidation during n-3 fatty acid and vitamin E supplementation in humans. Lipids. 1997, 32, 535-541.
33. H. Arnesen: n-3 fatty acids and revascularization procedures. Lipids. 2001, 36 Suppl, S103-106.
34. S. Glozman, P. Green, E. Yavin: Intraamniotic ethyl docosahexaenoate administration protects fetal rat brain from ischemic stress. J Neurochem. 1998, 70, 2484-2491.
35. P. Green, S. Glozman, E. Yavin: Ethyl docosahexaenoate-associated decrease in fetal brain lipid peroxide production is mediated by activation of prostanoid and nitric oxide pathways. Biochim Biophys Acta. 2001, 1531, 156-164.
36. M. Croset, M. Lagarde: In vitro incorporation and metabolism of icosapentaenoic and docosahexaenoic acids in human platelets - Effect on aggregation. Thromb Haemost. 1986, 56, 57-62.
37. D. C. Gaudette, B. J. Holub: Albumin-bound docosahexaenoic acid and collagen-induced human platelet reactivity. Lipids. 1990, 25, 166-169.
38. C. M. Nieuwenhuys, G. Hornstra: The effects of purified eicosapentaenoic and docosahexaenoic acids on arterial thrombosis tendency and platelet function in rats. Biochim Biophys Acta. 1998, 1390, 313-322.
39. D. Lemaitre, E. Véricel, A. Polette, M. Lagarde: Effects of fatty acids on human platelet glutathione peroxidase: Possible role of oxidative stress. Biochem Pharmacol. 1997, 53, 479-486.
40. A. Polette, D. Lemaitre, M. Lagarde, E. Véricel: N-3 fatty acid-induced lipid peroxidation in human platelets is prevented by catechins. Thromb Haemost. 1996, 75, 945-949.
41. E. Véricel, A. Polette, S. Bacot, C. Calzada, M. Lagarde: Proand antioxidant activities of docosahexaenoic acid on human blood platelets. J Thromb Haemost. 2003, 1, 566-572.
42. E. Véricel, C. Calzada, P. Chapuy, M. Lagarde: The influence of low intake of n-3 fatty acids on platelets in elderly people. Atherosclerosis. 1999, 147, 187-192.
43. E. Véricel, M. Croset, P. Sedivy, P. Courpron, M. Dechavanne, M. Lagarde: Platelets and aging. I. Aggregation, arachidonate metabolism and antioxidant status. Thromb Res. 1988, 49, 331-342.
44. E. Véricel, C. Rey, C. Calzada, P. Haond, P. H. Chapuy, M. Lagarde: Age-related changes in arachidonic acid peroxidation and glutathione-peroxidase activity in human platelets. Prostaglandins. 1992, 43, 75-85.
45. E. J. Corey, C. Shih, J. R. Cashman: Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proc Natl Acad Sci USA. 1983, 80, 3581-3584.
46. M. Croset, M. Guichardant, M. Lagarde: Different metabolic behavior of long-chain n-3 polyunsaturated fatty acids in human platelets. Biochim Biophys Acta. 1988, 961, 262-269.
47. S. F. O'Keefe, M. Lagarde, A. Grandgirard, J. L. Sebedio: Trans n-3 eicosapentaenoic and docosahexaenoic acid isomers exhibit different inhibitory effects on arachidonic acid metabolism in human platelets compared to the respective cis fatty acids. J Lipid Res. 1990, 31, 1241-1246.
48. 14C]docosahexaenoic acid by human platelets. J Biol Chem. 1983, 258, 9339-9343.
49. T. H. Lee, J. M. Mencia-Huerta, C. Shih, E. J. Corey, R. A. Lewis, K. F. Austen: Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. J Clin Invest. 1984, 74, 1922-1933.
50. S. Sawazaki, N. Salem Jr, H. Y. Kim: Lipoxygenation of docosahexaenoic acid by the rat pineal body. J Neurochem. 1994, 62, 2437-2447.
51. S. Hong, K. Gronert, P. R. Devchand, R. L. Moussignac, C. N. Serhan: Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J Biol Chem. 2003, 278, 14677-14687.
52. P. K. Mukherjee, V. L. Marcheselli, C. N. Serhan, N. G. Bazan: Neuroprotectin D1: A docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci USA. 2004, 101, 8491-8496.
53. W. J. Lukiw, J. G. Cui, V. L. Marcheselli, M. Bodker, A. Botkjaer, K. Gotlinger, C. N. Serhan, N. G. Bazan: A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest. 2005, 115, 2774-2783.
54. C. N. Serhan, K. Gotlinger, S. Hong, Y. Lu, J. Siegelman, T. Baer, R. Yang, S. P. Colgan, N. A. Petasis: Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: Assignments of dihydroxy-containing docosatrienes. J Immunol. 2006, 176, 1848-1859.
55. M. Croset, M. Lagarde: Stereospecific inhibition of PGH2-induced platelet aggregation by lipoxygenase products of icosaenoic acids. Biochem Biophys Res Commun. 1983, 112, 878-883.
56. M. Croset, A. Sala, G. Folco, M. Lagarde: Inhibition by lipoxygenase products of TXA2-like responses of platelets and vascular smooth muscle. 14-Hydroxy from 22:6n-3 is more potent than 12-HETE. Biochem Pharmacol. 1988, 37, 1275-1280.
57. P. Fonlupt, M. Croset, M. Lagarde: 12-HETE inhibits the binding of PGH2/TXA2 receptor ligands in human platelets. Thromb Res. 1991, 63, 239-248.
58. P.G. Swann, C. A. Parent, M. Croset, P. Fonlupt, M. Lagarde, V. L. Venton, G. C. Le Breton: Enrichment of platelet phospholipids with eicosapentaenoic acid and docosahexaenoic acid inhibits thromboxane A2/prostaglandin H2 receptor binding and function. J Biol Chem. 1990, 265, 21692-21697.
59. C. A. Parent, M. Lagarde, D. L. Venton, G. C. Le Breton: Selective modulation of the human platelet thromboxane A2/ prostaglandin H2 receptor by eicosapentaenoic and docosahexaenoic acids in intact platelets and solubilized platelet membranes. J Biol Chem. 1992, 267, 6541-6547.
60. Y. Bayon, M. Croset, D. Daveloose, F. Guerbette, V. Chirouze, J. Viret, J. C. Kader, M. Lagarde: Effect of specific phospholipid molecular species incorporated in human platelet membranes on thromboxane A2/prostaglandin H2 receptors. J Lipid Res. 1995, 36, 47-56.
61. I. A. Butovich: A one-step method of 10,17-dihydro(pero)xydocosahexa-4Z, 7Z,11E,13Z,15E,19Z-enoic acid synthesis by soybean lipoxygenase. J Lipid Res. 2006, 47, 854-863.